Arovella Therapeutics Ltd
ASX:ALA
Arovella Therapeutics Ltd
ASX:ALA
Price:
0.093
AUD
29.17%
Market Closed
Market Cap:
AU$112.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Arovella Therapeutics Ltd
ASX:ALA
|
AU |
|
W
|
World Fuel Services Corp
XBER:WFK
|
US |
|
dynaCERT Inc
TSX:DYA
|
CA |
|
D
|
DE&T Co Ltd
KOSDAQ:079810
|
KR |
Income Statement
Earnings Waterfall
Arovella Therapeutics Ltd
Arovella Therapeutics Ltd
Income Statement
Arovella Therapeutics Ltd
Arovella Therapeutics Ltd
Currency: AUD
| Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
-40%
|
0
-84%
|
0
+614%
|
1
+123%
|
0
-35%
|
0
-68%
|
0
+12%
|
0
+184%
|
1
+19%
|
1
+7%
|
|
| Gross Profit | ||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
-84%
|
(0)
N/A
|
0
N/A
|
0
+317%
|
0
-40%
|
0
-50%
|
0
+34%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(5)
|
(5)
|
(8)
|
(8)
|
(10)
|
(10)
|
(10)
|
(9)
|
(7)
|
(8)
|
(15)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(1)
|
(2)
|
(4)
|
(3)
|
(3)
|
(3)
|
|
| Research & Development |
0
|
0
|
(1)
|
(3)
|
(4)
|
(4)
|
(6)
|
(7)
|
(6)
|
(7)
|
(7)
|
|
| Depreciation & Amortization |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(4)
|
(0)
|
1
|
2
|
2
|
(5)
|
|
| Operating Income |
(5)
N/A
|
(5)
-3%
|
(8)
-65%
|
(8)
+1%
|
(10)
-26%
|
(10)
-1%
|
(10)
-6%
|
(9)
+15%
|
(6)
+28%
|
(8)
-20%
|
(14)
-91%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
(0)
|
(1)
|
0
|
(1)
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
6
|
|
| Pre-Tax Income |
(5)
N/A
|
(5)
-9%
|
(7)
-44%
|
(9)
-19%
|
(9)
+1%
|
(10)
-19%
|
(10)
0%
|
(9)
+14%
|
(6)
+28%
|
(8)
-20%
|
(8)
-6%
|
|
| Net Income | ||||||||||||
| Tax Provision |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(4)
|
(5)
|
(7)
|
(9)
|
(9)
|
(10)
|
(10)
|
(9)
|
(6)
|
(8)
|
(8)
|
|
| Net Income (Common) |
(4)
N/A
|
(5)
-27%
|
(7)
-44%
|
(9)
-19%
|
(9)
+1%
|
(10)
-19%
|
(10)
0%
|
(9)
+14%
|
(6)
+28%
|
(8)
-20%
|
(8)
-6%
|
|
| EPS (Diluted) |
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
